Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01517776
What this trial is testing

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

Who this might be right for
Gliomas
Martin-Luther-Universität Halle-Wittenberg 28
Testing effectiveness (Phase 2)Ended earlyNCT05737212
What this trial is testing

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Who this might be right for
Recurrent High-grade GliomaRecurrent GlioblastomaRecurrent Anaplastic Astrocytoma+1 more
Dawonmedax Co., Ltd. 7
Not applicableLooking for participantsNCT05979064
What this trial is testing

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+5 more
Northwell Health 10
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Large-scale testing (Phase 3)Active Not RecruitingNCT03663725
What this trial is testing

Treatment Intensification With Temozolomide in Adults With a Glioblastoma

Who this might be right for
Glioblastoma
Centre Oscar Lambret 486
Not applicableUnknownNCT05556382
What this trial is testing

Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity

Who this might be right for
Glioblastoma
Istituto Clinico Humanitas 30
Very early researchStudy completedNCT02768389
What this trial is testing

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

Who this might be right for
GlioblastomaBrain Tumor
Case Comprehensive Cancer Center 18
Early research (Phase 1)Ended earlyNCT02209376
What this trial is testing

Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma

Who this might be right for
Patients With Residual or Reccurent EGFRvIII+ Glioma
University of Pennsylvania 11
Testing effectiveness (Phase 2)Study completedNCT02799238
What this trial is testing

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma

Who this might be right for
Glioblastoma
CytoVac A/S 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT05463848
What this trial is testing

Surgical Pembro +/- Olaparib w TMZ for rGBM

Who this might be right for
GlioblastomaRecurrent Glioblastoma
L. Nicolas Gonzalez Castro, MD, PhD 52
Large-scale testing (Phase 3)UnknownNCT03008148
What this trial is testing

Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Johnpro Biotech, Inc. 288
Testing effectiveness (Phase 2)Study completedNCT00800917
What this trial is testing

Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Rigshospitalet, Denmark 12
Not applicableStudy completedNCT01929720
What this trial is testing

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Who this might be right for
Anxiety DisorderWorryUncertainty+19 more
Ohio State University Comprehensive Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00003574
What this trial is testing

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00157703
What this trial is testing

G207 Followed by Radiation Therapy in Malignant Glioma

Who this might be right for
Malignant Glioma
MediGene 9
Testing effectiveness (Phase 2)Looking for participantsNCT06936046
What this trial is testing

Enhanced Adjuvant Therapy for Newly Diagnosed GBM With Partial Surgical Resection or Short-term Progression

Who this might be right for
Glioblastoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 200
Not applicableNot Yet RecruitingNCT07197086
What this trial is testing

Clinical and Treatment Determinant of Prognosis in Glioblastoma

Who this might be right for
Glioblastoma
Assiut University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019262
What this trial is testing

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
John Flickinger 2
Large-scale testing (Phase 3)Study completedNCT02017717
What this trial is testing

The Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

Who this might be right for
Recurrent Glioblastoma
Bristol-Myers Squibb 529
Testing effectiveness (Phase 2)Active Not RecruitingNCT03212274
What this trial is testing

Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
Advanced Malignant Solid NeoplasmGlioblastomaRecurrent Cholangiocarcinoma+4 more
National Cancer Institute (NCI) 89
Next Page